Last spring, published research suggested angiotensin receptor blockers could lower the risk for ventilation and vasopressors in men with COVID-19. Just this week, however, an article released by the Journal of the American Medical Association noted that ARBs do not improve outcomes in patients hospitalized with COVID-19. The trial included 787 patients at 17 hospitals in Australia and India and covered the period from May 2020 to November 2021. The vast majority of patients (n=778), …
Read More